Cardlytics (CDLX) Tops Q2 EPS by 20c

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.65), $0.20 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $75.4 million versus the consensus estimate of $76.5 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Middleby board approves spin-off of food processing unit Midera